Opinion|Videos|June 6, 2024
Obstacles in Adapting Diabetes Technology to Individual Needs
A diabetes expert investigates the personal factors impacting patients' adoption of diabetes devices and technologies, while concurrently exploring specific plan policies, wellness initiatives, and benefit designs that could most effectively and equitably enhance diabetes outcomes across diverse demographic groups.
Advertisement
Episodes in this series
- Beyond clinical appropriateness, what personal factors (e.g., technological literacy, financial concerns) might impact members' adoption of diabetes devices or technologies?
- What specific plan policies, wellness initiatives, or benefit design changes do you think could most effectively and equitably improve diabetes outcomes across different demographic groups within your covered population?
Advertisement
Related to this article
In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than those using finger-stick testing.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CVS Health is splitting in two, according to news reports
2
Jeremy Gaskill on moving from Humana to Geisinger Health Plan
3
The CVS Health split. How separate will the two companies really be?
4
A Democratic Congress likely means more oversight for payers, not a Medicaid rollback
5